Upgrade to SI Premium - Free Trial

Needham Reiterates Buy Rating on Medtronic, Inc. (MDT)

September 17, 2026 6:02 AM
Needham analyst Michael Matson reiterated a Buy rating and $114.00 price target on Medtronic, Inc. (NYSE: MDT).The analyst commented: "On ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments